Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support

European Journal of Heart Failure

Volumn 11, Issue 10, 2009, Pages 1000-1004

  Vrtovec, Bojan ^a   Radovancevic, Rajko ^a   Delgado, Reynolds M ^a   Radovancevic, Branislav ^a   Bracey, Arthur W ^a   Gregoric, Igor D ^a   Frazier, O H ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Anaemia; Left ventricular assist device (LVAD); Survival

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; ADVANCED HEART FAILURE; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANEMIA; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; LONG-TERM CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 70349687381     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp110     Document Type: Article

References (25)

1. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA, CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113:986-994.
2. Valeur N, Nielsen OW, McMurray JJ, Torp-Pedersen C, Kober L. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail 2006;8:577-584.
3. Silverberg DS, Wexler D, Iaina A, Schwartz D. The role of correction of anaemia in patients with congestive heart failure: a short review. Eur J Heart Fail 2008;10: 819-823.
4. O'Meara E, Murphy C, McMurray JJ. Anemia and heart failure. Curr Heart Fail Rep 2004;1:176-182.
5. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, Delgado R, Frazier OH. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005;11:133-138.
6. Stringham JC, Bull DA, Fuller TC, Kfoury AG, Taylor DO, Renlund DG, Karwande SV. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant 1999;18: 160-165.
7. Loebe M, Koster A, Sanger S, Potapov EV, Kuppe H, Noon GP, Hetzer R. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J 2001;47:272-274.
8. Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, Robertson K, Radovancevic B, Frazier OH. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg 2003;76:1167-1170.
9. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994;13:1125-1132.
10. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 2005;149:391-401.
11. Inglis SC, Stewart S, Papachan A, Vaghela V, Libhaber C, Veriava Y, Sliwa K. Anaemia and renal function in heart failure due to idiopathic dilated cardiomyopathy. Eur J Heart Fail 2007;9:384-390.
12. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004;110:149-154.
13. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003;107:223-225.
14. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001;16:36-40.
15. Hogenhuis J, Voors AA, Jaarsma T, Hoes AW, Hillege HL, Kragten JA, van Veldhuisen DJ. Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure. Eur J Heart Fail 2007;9:787-794.
16. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Heart Fail 2000; 2:393-398.
17. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352: 1011-1023.
18. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005;95: 3C-8C.
19. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003;361:1077-1083.
20. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 1999;100: 1189-1193.
21. Clark AL, Loebe M, Potapov EV, Egerer K, Knosalla C, Hetzer R, Anker SD. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J 2001;22:2275-2283.
22. Holdy K, Dembitsky W, Eaton LL, Chillcott S, Stahovich M, Rasmusson B, Pagani F. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 2005;24:1690-1696. (Pubitemid 41396471)
23. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
24. Geisberg C, Nading MA, Listerman J, Huang R, Goring J, Butler J. Anemia in heart failure may warrant more aggressive listing for cardiac transplantation. Transplant Proc 2006;38:1499-1500.
25. Silverberg DS, Wexler D, Blum M, Iaina A, Sheps D, Keren G, Schwartz D. Erythropoietin in heart failure. Semin Nephrol 2005;25:397-403.